Plasma alpha-synuclein is decreased in subjects with Parkinson's disease.
Alpha-synuclein (alphaSN) is implicated in Parkinson's disease (PD) and is the major component of Lewy bodies (LBs). Although alphaSN is mainly expressed in neuronal cells and exists as a cytoplasmic protein, it has been found in body fluids including cerebrospinal fluid and blood. This study explored plasma alphaSN as a diagnostic marker for PD. Western blot analysis was used to characterize plasma alphaSN compared to brain alphaSN. Plasma alphaSN of 16 kDa migrates with the same mobility as its brain counterpart and recombinant alphaSN on denatured polyacrylamide gels and reacted with three different antibodies against the C-terminal and NAC regions of the alphaSN protein. The alphaSN levels in plasma from PD subjects are significantly lower than that in age-matched controls (p=0.001), and the alphaSN levels in patients with early-onset PD are lower than that in both late-onset PD and controls. This initial study indicates that measurement of alphaSN in plasma can provide support for a clinical diagnosis of Parkinson's disease and warrants further study in a larger population.
Li
Qiao-Xin
QX
Department of Pathology, The University of Melbourne, Parkville, Victoria 3010, Australia. q.li@unimelb.edu.au
Mok
Su San
SS
Laughton
Katrina M
KM
McLean
Catriona A
CA
Cappai
Roberto
R
Masters
Colin L
CL
Culvenor
Janetta G
JG
Horne
Malcolm K
MK
D000368:Aged; D015153:Blotting, Western / Q000379:methods; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000097:blood*; D051844:alpha-Synuclein / Q000097:blood*
D051844:alpha-Synuclein